Abstract

A series of dinuclear compounds of [Ru(bpy)(2)(tpphz)Ln(TTA)(3)](PF(6))(2) (tpphz = tetrapyrido[3,2-a:2',3'-c:3'',2''-h:3''',4'''-j]phenazine; Ln = Er(III), Nd(III), Yb(III) and Gd(III); TTA = 2-thenoyltrifluoroacetone) have been prepared by attachment of a [Ln(TTA)(3)] fragment at the vacant diimine site of the luminescent mononuclear complex [Ru(bpy)(2)(tpphz)](PF(6))(2). In the solid state, in CH(2)Cl(2) solution and in Tris-HCl buffer solution of these dinuclear complexes Ru-Ln, sensitized near-infrared (NIR) luminescence is observed from Nd and Yb centres following excitation of the d-block unit, which results from the effective Ru → Ln (Ln = Nd, Yb) energy transfer, but no Er-based NIR luminescence is produced. The (3)MLCT (MLCT = metal to ligand charge transfer) emission is partly quenched in the Ru-Nd complex, slightly increased in the Ru-Yb complex, and is not changed in the Ru-Ercomplex. Interestingly, alpha-fetal protein (AFP) tends to decrease the NIR luminescence intensity of the Ru-Nd complex in Tris-HCl buffer solution. A novel NIR luminescent method for the determination of AFP was developed with a linear range of 0.5-18 ng mL(-1), and a detection limit of 0.2 ng mL(-1) based on 3 times the ratio of the signal-to-noise. Considering the attractive features, such as good selectivity, stability and rapidity, the proposed NIR luminescent method provides promising potential for AFP detection in clinical diagnosis and biomedical applications.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call